Kaiser Permanente Northwest Kaiser

Denver, Colorado 80209

0 studies enrolling now · 2 studies all time

What they study most

Acute Myeloid Leukemia (AML) With, Breast Cancer, FLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD)

Studies at this site

• Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor — Completed
• Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy — NO_LONGER_AVAILABLE